|

BMS-986165 Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since August 2026

Pipeline

Phase 4: 1

Top Sponsors

  • Bristol-Myers Squibb1

Indications

  • Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)1
  • Systemic Lupus Erythematosus (SLE)1
  • Lupus1

Farmington, Connecticut1 trial

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Local Institution - 0001

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.